Case number 1:21-cv-01411
Allergan, Inc. et al v. Revance Therapeutics, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 9, 2023 | 251 | NOTICE OF SERVICE of Defendants Revance Therapeutics, Inc. and Ajinomoto Althea, Inc. d/b/a Ajinomoto Bio-Pharma Services' Supplemental Response and Objections to Plaintiffs' Interrogatory No. 3 filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 10/09/2023) (2) |
| Oct 6, 2023 | 245 | NOTICE OF SERVICE of 1) Defendants' Notice of Deposition of Diana Burman; 2) Defendants' Notice of Deposition of Dianne Hodges; and 3) Defendants' Notice of Deposition of Jag Dosanjh filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 10/06/2023) (2) |
| Oct 6, 2023 | 246 | REDACTED VERSION of 230 Letter by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # 1 Exhibit A - E)(Gaza, Anne) (Entered: 10/06/2023) (0) |
| Oct 6, 2023 | 247 | REDACTED VERSION of 231 Letter, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibits 1-21)(Tigan, Jeremy) Modified on 10/8/2023 (nms). (Entered: 10/06/2023) (0) |
| Oct 6, 2023 | 248 | NOTICE OF SERVICE of Plaintiffs' Objections and Supplemental Responses to Defendants' First Set of Interrogatories (Nos. 1-7) filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 10/06/2023) (3) |
| Oct 6, 2023 | 249 | REDACTED VERSION of 232 Letter, by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-6)(Gaza, Anne) Modified on 10/8/2023 (nms). (Entered: 10/06/2023) (0) |
| Oct 6, 2023 | 250 | REDACTED VERSION of 233 Letter, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Tigan, Jeremy) Modified on 10/8/2023 (nms). (Entered: 10/06/2023) (0) |
| Oct 5, 2023 | 244 | STIPULATION and Proposed Order to Extend Time to file redacted versions of D.I. 230, 231, 232, 233 to October 6, 2023 - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 10/6/2023 (nms). (Entered: 10/05/2023) (1) |
| Sep 28, 2023 | 241 | NOTICE OF SERVICE of Defendants Revance Therapeutics, Inc. and Ajinomoto Althea, Inc. d/b/a Ajinomoto Bio-Pharma Services' First Supplemental Response and Objections to Plaintiffs' Interrogatory No. 2 filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 09/28/2023) (2) |
| Sep 28, 2023 | 242 | NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiffs' Third Set of Interrogatories (Nos. 15-18) filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 09/28/2023) (2) |
| Sep 28, 2023 | 243 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' Second Set of Interrogatories (Nos. 8-12); (2) Plaintiffs' Objections and Responses to Defendants' Third Set of Requests for the Production of Documents and Things (Nos. 165-192); and (3) Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Admission (Nos. 1-20) filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 09/28/2023) (3) |
| Sep 27, 2023 | 240 | NOTICE OF SERVICE of Plaintiffs' Notice of Deposition of Meagan Clevenger filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 09/27/2023) (3) |
| Sep 26, 2023 | 235 | STIPULATION and Proposed Order to Extend Time - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 9/26/2023 (nms). (Entered: 09/26/2023) (2) |
| Sep 26, 2023 | 236 | ORAL ORDER: Having been advised by the parties that their discovery disputes have been resolved, IT IS ORDERED that the Joint Motion for Teleconference to Resolve Discovery Disputes (D.I. 220 ) is DISMISSED and the teleconference scheduled for today is CANCELLED. Ordered by Judge Jennifer L. Hall on 9/26/2023. (ceg) (Entered: 09/26/2023) (0) |
| Sep 26, 2023 | 237 | SO ORDERED Granting 235 STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 9/26/2023. (nms) (Entered: 09/26/2023) (2) |
| Sep 26, 2023 | 238 | ANSWERING BRIEF in Opposition re 218 MOTION for Reargument and Reconsideration of the Court's Construction of "Clarified Culture" filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..Reply Brief due date per Local Rules is 10/3/2023. (Tigan, Jeremy) (Entered: 09/26/2023) (12) |
| Sep 26, 2023 | 239 | STIPULATION and Proposed Order to Extend Time to file redacted versions of discovery dispute letters (D.I. 230, 231, 232, 233) to October 5, 2023 - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 9/27/2023 (nms). (Entered: 09/26/2023) (1) |
| Sep 25, 2023 | 234 | NOTICE OF SERVICE of Defendants' Second Supplemental Rule 26(a)(1) Initial Disclosures filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 09/25/2023) (2) |
| Sep 21, 2023 | 232 | [SEALED] Letter to The Honorable Jennifer L. Hall, from Anne Shea Gaza, regarding opposition to Allergan's discovery dispute letter. (Attachments: # 1 Exhibits 1-6)(Gaza, Anne) (Main Document 232 replaced on 9/22/2023) (ceg). Modified on 9/22/2023 (nms). (Entered: 09/21/2023) (0) |
| Sep 21, 2023 | 233 | [SEALED] Letter to The Honorable Jennifer L. Hall, from Jeremy A. Tigan, regarding response to Defendants' motion to compel (D.I. 230 ). (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Tigan, Jeremy) Modified on 9/22/2023 (nms). (Entered: 09/21/2023) (0) |
| Sep 19, 2023 | 228 | NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 09/19/2023) (3) |
| Sep 19, 2023 | 229 | CLAIM CONSTRUCTION ORDER. Signed by Judge Richard G. Andrews on 9/19/2023. (nms) (Entered: 09/19/2023) (4) |
| Sep 19, 2023 | 230 | [SEALED] Letter to The Honorable Jennifer L. Hall, from Anne Shea Gaza, regarding motion to compel (D.I. 220 ). (Attachments: # 1 Exhibits A-E, # 2 Proposed Order)(Gaza, Anne) Modified on 9/20/2023 (nms). (Entered: 09/19/2023) (0) |
| Sep 19, 2023 | 231 | [SEALED] Letter to The Honorable Jennifer L. Hall, from Jeremy A. Tigan, regarding discovery dispute (D.I. 220 ). (Attachments: # 1 Exhibits 1-21)(Tigan, Jeremy) (Main Document 231 replaced on 9/20/2023) (ceg). Modified on 9/20/2023 (nms). (Entered: 09/19/2023) (0) |
| Sep 18, 2023 | 227 | SO ORDERED, re 225 STIPULATION and Proposed Order to Extend Time for Certain Case Deadlines to Various Dates. Signed by Judge Richard G. Andrews on 9/18/2023. (lah) (Entered: 09/18/2023) (2) |
| Sep 15, 2023 | 221 | ORAL ORDER Setting Teleconference: The Court has reviewed the Joint Motion for Teleconference to Resolve Discovery Disputes (D.I. 220 ). A discovery dispute teleconference is scheduled for September 26, 2023 at 3:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than September 19, 2023, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than September 21, 2023, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Jennifer L. Hall on 9/15/2023. (ceg) (Entered: 09/15/2023) (0) |
| Sep 15, 2023 | 222 | NOTICE OF SERVICE of Defendants' Notice of Deposition of Chad Lindemann Pursuant to Fed. R. Civ. P. 30(b)(1) filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 09/15/2023) (2) |
| Sep 15, 2023 | 223 | STIPULATION and [Proposed] Order of Dismissal of Certain Claims and Defenses, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 9/15/2023 (nms). (Entered: 09/15/2023) (2) |
| Sep 15, 2023 | 224 | SO ORDERED Granting 223 Stipulation and Proposed Order of Dismissal of Certain Claims and Defenses. Signed by Judge Richard G. Andrews on 9/15/2023. (nms) (Entered: 09/15/2023) (2) |
| Sep 15, 2023 | 225 | STIPULATION and Proposed Order to Extend Time for Certain Case Deadlines to Various Dates - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 9/18/2023 (lah). (Entered: 09/15/2023) (2) |
| Sep 15, 2023 | 226 | Proposed Claim Construction Order, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 9/17/2023 (nms). (Entered: 09/15/2023) (4) |
| Sep 14, 2023 | 220 | Joint Motion for Teleconference to Resolve Discovery Disputes - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 9/14/2023 (nms). (Entered: 09/14/2023) (3) |
| Sep 13, 2023 | 219 | NOTICE of Revised Subpoenas to Darren Hassey and Vickie Laurent by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc. (Attachments: # 1 Exhibits 1-2)(Tigan, Jeremy) (Entered: 09/13/2023) (0) |
| Sep 12, 2023 | 217 | SO ORDERED Granting 216 STIPULATION and Proposed Order to Extend Time to file (1) a proposed order pursuant to the Markman Opinion and (2) any motions for reargument or reconsideration of the Markman Opinion to September 15, 2023. Signed by Judge Richard G. Andrews on 9/12/2023. (nms) (Entered: 09/12/2023) (2) |
| Sep 12, 2023 | 218 | MOTION for Reargument and Reconsideration of the Court's Construction of "Clarified Culture" - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # 1 Exhibit 1, # 2 Proposed Order)(Gaza, Anne) Modified on 9/12/2023 (nms). (Entered: 09/12/2023) (0) |
| Sep 11, 2023 | 216 | STIPULATION and Proposed Order to Extend Time to file (1) a proposed order pursuant to the Markman Opinion and (2) any motions for reargument or reconsideration of the Markman Opinion to September 15, 2023 - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 9/12/2023 (nms). (Entered: 09/11/2023) (2) |
| Sep 7, 2023 | 215 | STIPULATION and Proposed Order to Extend Time to submit a proposed order pursuant to the Courts Memorandum Opinion regarding claim construction to September 11, 2023 - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 9/7/2023 (nms). (Entered: 09/07/2023) (2) |
| Sep 5, 2023 | 214 | STIPULATION TO EXTEND TIME for the parties to submit a proposed order pursuant to the Court's Memorandum Opinion regarding claim construction to September 7, 2023 - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) (Entered: 09/05/2023) (2) |
| Aug 30, 2023 | 213 | NOTICE OF SERVICE of 1) Defendants' First Set of Requests for Admission (Nos. 1 - 20) to Plaintiffs; 2) Defendants' Second Set of Interrogatories to Plaintiffs (Nos. 8 - 12); and 3) Defendants' Third Set of Requests for the Production of Documents and Things (Nos. 165 - 192) To Plaintiffs filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 08/30/2023) (2) |
| Aug 29, 2023 | 211 | MEMORANDUM OPINION. Within five days the parties shall submit a proposed order consistent with this Memorandum Opinion. Signed by Judge Richard G. Andrews on 8/29/2023. (lah) (Entered: 08/29/2023) (16) |
| Aug 29, 2023 | 212 | NOTICE OF SERVICE of Plaintiffs' Third Set of Interrogatories (Nos. 15-18) to Defendants filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 08/29/2023) (3) |
| Aug 25, 2023 | 207 | NOTICE of Subpoenas to Michelle Frazier, Darren Hassey, Abhay Joshi, Vickie Laurent, Curtis Ruegg and Priscilla Too by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc. (Attachments: # 1 Exhibits 1-6)(Tigan, Jeremy) (Entered: 08/25/2023) (0) |
| Aug 25, 2023 | 208 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Notice of Rule 30(b)(6) Deposition of Plaintiffs filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 08/25/2023) (3) |
| Aug 25, 2023 | 209 | MOTION for Pro Hac Vice Appearance of Attorney Marsha Rose Gillentine, Ph.D., Nirav N. Desai, Christopher M. Gallo, Ph.D., Tyler C. Liu, Adil B. Moghal, Ph.D. and Louis P. Panzica, Jr. - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) (Entered: 08/25/2023) (10) |
| Aug 25, 2023 | 210 | NOTICE OF SERVICE of 1) Defendant Ajinomoto Althea, Inc. D/B/A Ajinomoto-Bio-Pharma Services' Responses and Objections to Plaintiffs' Notice of Deposition of Defendants Pursuant To Fed. R. Civ. P. 30(B)(6); and 2) Defendant Revance Therapeutics, Inc.'s Responses and Objections to Plaintiffs' Notice of Deposition of Defendants Pursuant to Fed. R. Civ. P. 30(B)(6) filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 08/25/2023) (2) |
| Aug 21, 2023 | 206 | NOTICE OF SERVICE of Defendants Revance Therapeutics, Inc. and Ajinomoto Althea, d/b/a Ajinomoto Bio-Pharma Services' Responses and Objections to Plaintiffs' Second Set of Interrogatories (Nos. 12-14) filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 08/21/2023) (2) |
| Aug 18, 2023 | 205 | NOTICE OF SERVICE of Plaintiffs' Notice of Deposition of Conor Gallagher filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 08/18/2023) (3) |
| Aug 16, 2023 | 203 | NOTICE OF SERVICE of Plaintiffs' Objections and Supplemental Responses to Defendants' First Set of Interrogatories (Nos. 1-7) filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 08/16/2023) (3) |
| Aug 16, 2023 | 204 | NOTICE OF SERVICE of Defendants Revance Therapeutics, Inc. and Ajinomoto Althea, d/b/a Ajinomoto Bio-Pharma Services' Supplemental Responses and Objections to Plaintiffs First Set of Interrogatories (Nos. 1 and 4-11) filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 08/16/2023) (2) |
| Aug 14, 2023 | 202 | NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiffs' First Set of Requests for Admission of Authenticity (Nos. 1-17) and Requests for Admission to Defendants (Nos. 1-17) filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Gaza, Anne) (Entered: 08/14/2023) (2) |
| Aug 11, 2023 | 200 | REDACTED VERSION of 186 Notice to Take Deposition by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) (Entered: 08/11/2023) (12) |
| Aug 11, 2023 | 201 | ORAL ORDER: For the reasons discussed at the teleconference today, August 11, 2023, non-party BioSentinel's Motion for Protective Order (D.I. 168 ) is DENIED. The portions of the license agreement in question shall be produced unredacted subject to the highest designation under the Protective Order entered in this case (D.I. 70 ). The Court's prior order at D.I. 177 is withdrawn. Ordered by Judge Jennifer L. Hall on 8/11/2023. (ceg) (Entered: 08/11/2023) (0) |
| Aug 10, 2023 | 196 | NOTICE OF SERVICE of 1. Defendants' Notice of Deposition of Wajdie Ahmad Pursuant to Fed. R. Civ. P. 30(b)(1); 2. Defendants' Notice of Deposition of Ronald Bates Pursuant to Fed. R. Civ. P. 30(b)(1); 3. Defendants' Notice of Deposition of Stephen Donovan Pursuant to Fed. R. Civ. P. 30(b)(1); 4. Defendants' Notice of Deposition of Ester Fernandez-Salas Pursuant to Fed. R. Civ. P. 30(b)(1); 5. Defendants' Notice of Deposition of Jamie E. Gonzales Pursuant to Fed. R. Civ. P. 30(b)(1); 6. Defendants' Notice of Deposition of Terrence Hunt Pursuant to Fed. R. Civ. P. 30(b)(1); 7. Defendants' Notice of Deposition of Stacey Klinkenborg Pursuant to Fed. R. Civ. P. 30(b)(1); 8. Defendants' Notice of Deposition of Mingjiang Luo Pursuant to Fed. R. Civ. P. 30(b)(1); 9. Defendants' Notice of Deposition of Jason Y. Paik Pursuant to Fed. R. Civ. P. 30(b)(1); 10. Defendants' Notice of Deposition of Hemant A. Patel Pursuant to Fed. R. Civ. P. 30(b)(1); 11. Defendants' Notice of Deposition of Lance E. Steward Pursuant to Fed. R. Civ. P. 30(b)(1); 12. Defendants' Notice of Deposition of Jennifer Ton Pursuant to Fed. R. Civ. P. 30(b)(1); 13. Defendants' Notice of Deposition of Huong Tran Pursuant to Fed. R. Civ. P. 30(b)(1); 14. Defendants' Notice of Deposition of Ping Wang Pursuant to Fed. R. Civ. P. 30(b)(1); and 15. Defendants' Notice of Deposition of Hui Xiang Pursuant to Fed. R. Civ. P. 30(b)(1). filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Gaza, Anne) (Entered: 08/10/2023) (3) |
| Aug 10, 2023 | 197 | REDACTED VERSION of 186 Notice to Take Deposition by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) (Entered: 08/10/2023) (6) |
| Aug 10, 2023 | 198 | REDACTED VERSION of 187 Notice to Take Deposition by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) (Entered: 08/10/2023) (6) |
| Aug 10, 2023 | 199 | DEFICIENCY NOTICE by the Court issued to by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., and Allergan, Inc. re 197 Redacted Document. Upon review it was determined the redacted filing submitted at D.I. 197 was not a correct redaction for what was submitted at D.I. 186 . Counsel is to refile a redaction for D.I. 186 . (nms) (Entered: 08/10/2023) (0) |
| Aug 9, 2023 | 195 | NOTICE OF SERVICE of (1) Plaintiffs' Notice of Deposition of Mung Bernardo, (2) Plaintiffs' Notice of Deposition of Bryan Bullock, (3) Plaintiffs' Notice of Deposition of Maria Green, (4) Plaintiffs' Notice of Deposition of Kellie Lao, (5) Plaintiffs' Notice of Deposition of Vickie Laurent, (6) Plaintiffs' Notice of Deposition of Allen Li, (7) Plaintiffs' Notice of Deposition of Tyson Smyth, (8) Plaintiffs' Notice of Deposition of Joanna Stebbins and (9) Plaintiffs' Notice of Deposition of Savitha Venkatesh filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 08/09/2023) (3) |
| Aug 8, 2023 | 194 | STIPULATION and Proposed Order to Extend Time to file redacted versions (D.I. 186 , 187 ) to August 10, 2023 - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 8/9/2023 (nms). (Entered: 08/08/2023) (2) |
| Aug 4, 2023 | 192 | REDACTED VERSION of 141 Joint Claim Construction Brief, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 8/4/2023 (nms). (Entered: 08/04/2023) (30) |
| Aug 4, 2023 | 193 | NOTICE of Address Change for Pro Hac Vice Counsel by Ajinomoto Althea, Inc., Revance Therapeutics, Inc. (Wilson, Samantha) (Entered: 08/04/2023) (3) |
| Aug 2, 2023 | 191 | STIPULATION and Proposed Order to Extend Time to file redacted versions of D.I. 186 and D.I. 187 to August 8, 2023 - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 8/2/2023 (nms). (Entered: 08/02/2023) (2) |
| Aug 1, 2023 | 190 | NOTICE OF SERVICE of Defendants' Deposition Notice Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 08/01/2023) (2) |
| Jul 31, 2023 | 189 | ORDER: The Unopposed Motion (D.I. 158 ) is GRANTED. The redacted versions of the Parties' Joint Claim Construction Brief (D.I. 159 ) and Exhibits D and E (D.I. 159 ) shall be filed as the redacted versions. The original and unredacted versions of D.I. 141 and 142 -1 shall remain sealed. Signed by Judge Richard G. Andrews on 7/31/2023. (lah) (Entered: 07/31/2023) (1) |
| Jul 27, 2023 | 188 | MOTION for Pro Hac Vice Appearance of Attorney Felix A. Eyzaguirre - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) (Entered: 07/27/2023) (4) |
| Jul 26, 2023 | 186 | [SEALED] NOTICE to Take Deposition of Revance Therapeutics, Inc. on a mutually agreed upon date and time filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 07/26/2023) (0) |
| Jul 26, 2023 | 187 | [SEALED] NOTICE to Take Deposition of Ajinomoto Althea, Inc. d/b/a Ajinomoto Bio Pharma Services on a mutually agreed upon date and time filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 07/26/2023) (0) |
| Jul 21, 2023 | 185 | NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories (Nos. 12-14) to Defendants filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 07/21/2023) (3) |
| Jul 17, 2023 | 184 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission to Defendants filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 07/17/2023) (3) |
| Jul 13, 2023 | 183 | MOTION for Pro Hac Vice Appearance of Attorney Robert D. Fish - filed by BioSentinel, Inc.. (Attachments: # 1 Certification of Robert D. Fish)(Haney, Megan) (Entered: 07/13/2023) (0) |
| Jul 12, 2023 | 180 | NOTICE OF SERVICE of Defendants' Second Supplemental Preliminary Invalidity Contentions filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 07/12/2023) (2) |
| Jul 12, 2023 | 181 | NOTICE OF SERVICE of 1) Defendants' Supplemental Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; and 2) Defendants' Supplemental Rule 26(a)(1) Initial Disclosures. filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 07/12/2023) (2) |
| Jul 12, 2023 | 182 | ORAL ORDER: Having received Allergan's letter (D.I. 178), and BioSentinel's response (D.I. 179), the Court shall hold a teleconference on August 11, 2023 at 11:00 am to hear the parties' positions. The parties shall call the Court's conference line at (877) 336-1829, access code: 7090640. Until then, the Court's July 7, 2023 Order (D.I. 177) stands. Ordered by Judge Jennifer L. Hall on 7/12/2023. (ceg) (Entered: 07/12/2023) (0) |
| Jul 10, 2023 | 179 | Letter to The Honorable Jennifer L. Hall, from John C. Phillips, Jr., regarding the Court's order granting Biosentinel's motion for protective order (D.I. 177 ) and Plaintiffs' subsequent request that the Court withdraw the Order (D.I. 178 ). (Attachments: # 1 Exhibit A)(Phillips, John) Modified on 7/10/2023 (nms). (Entered: 07/10/2023) (0) |
| Jul 7, 2023 | 177 | ORDER granting 168 Non-Party BioSentinel, Inc.'s Motion for Protective Order. Signed by Judge Jennifer L. Hall on 7/7/2023. (ceg) (Entered: 07/07/2023) (2) |
| Jul 7, 2023 | 178 | Letter to The Honorable Jennifer L. Hall, from Jeremy A. Tigan, regarding Plaintiffs' response to the Court's July 7, 2023 Order (D.I. 177 ). (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Tigan, Jeremy) Modified on 7/7/2023 (nms). (Entered: 07/07/2023) (0) |
| Jul 6, 2023 | 176 | REDACTED VERSION of 170 Exhibit to a Document by BioSentinel, Inc.. (Phillips, John) (Entered: 07/06/2023) (23) |
| Jul 5, 2023 | 175 | CERTIFICATE of Service for 170 Sealed Exhibit, by BioSentinel, Inc.. (Haney, Megan) Modified on 7/5/2023 (nms). (Entered: 07/05/2023) (2) |
| Jul 3, 2023 | 174 | Letter to The Honorable Jennifer L. Hall, from Samantha G. Wilson, regarding response to Non-Party BioSentinel's Motion for Protective Order. (Wilson, Samantha) Modified on 7/5/2023 (nms). (Entered: 07/03/2023) (2) |
| Jun 30, 2023 | 173 | REDACTED VERSION of 159 Exhibit to a Document by Revance Therapeutics, Inc.. (Wilson, Samantha) (Entered: 06/30/2023) (30) |
| Jun 29, 2023 | 168 | MOTION for Protective Order - filed by BioSentinel, Inc.. (Attachments: # 1 Text of Proposed Order)(Phillips, John) (Entered: 06/29/2023) (0) |
| Jun 29, 2023 | 169 | Letter to the Honorable Jennifer L. Hall, from John C. Phillips, Jr., regarding Motion for Protective Order (D.I. 168 ). (Attachments: # 1 Declaration)(Phillips, John) Modified on 6/29/2023 (nms). (Entered: 06/29/2023) (0) |
| Jun 29, 2023 | 170 | [SEALED] Exhibit A to 169 Letter, by BioSentinel, Inc.. (Phillips, John) Modified on 6/29/2023 (nms). (Entered: 06/29/2023) (0) |
| Jun 29, 2023 | 171 | Letter to The Honorable Richard G. Andrews, from Anne Shea Gaza, regarding Defendants' revised proposed construction for the disputed term "clarified culture". (Gaza, Anne) Modified on 6/29/2023 (nms). (Entered: 06/29/2023) (1) |
| Jun 29, 2023 | 172 | Letter to The Honorable Richard G. Andrews from Jack B. Blumenfeld regarding List of Asserted Claims. (Blumenfeld, Jack) (Entered: 06/29/2023) (2) |
| Jun 27, 2023 | 165 | MOTION for Exemption of Persons from the Court's May 15, 2023 Standing Order on Personal Devices - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Proposed Order)(Tigan, Jeremy) Modified on 6/27/2023 (nms). (Entered: 06/27/2023) (0) |
| Jun 27, 2023 | 166 | ORDER Granting 165 Motion for Exemption of Persons from the Court's May 15, 2023 Standing Order on Personal Devices. Signed by Judge Richard G. Andrews on 6/27/2023. (nms) (Entered: 06/27/2023) (2) |
| Jun 27, 2023 | 167 | Joint letter to The Honorable Richard G. Andrews, from Anne Shea Gaza, regarding "substantially APF process" and "animal product free" terms at June 28, 2023 Markman hearing. (Gaza, Anne) Modified on 6/28/2023 (nms). (Entered: 06/27/2023) (1) |
| Jun 26, 2023 | 163 | ORAL ORDER: The Markman Hearing scheduled for 6/28/2023, will now commence at 9:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 6/26/2023. (nms) (Entered: 06/26/2023) (0) |
| Jun 26, 2023 | 164 | NOTICE OF SERVICE of (1) Plaintiffs' Rule 26 Initial Disclosures and (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 06/26/2023) (3) |
| Jun 23, 2023 | 157 | ORAL ORDER: In the Joint Claim Construction Brief (D.I. 141 ), the parties suggest that the dispute on terms 3, 4, and 5 might be resolved. The parties are requested to submit a joint letter by noon on Monday updating the Court on that issue, and, if the dispute is resolved, stating the agreed upon construction or other resolution of the issue. Ordered by Judge Richard G. Andrews on 6/23/2023. (nms) (Entered: 06/23/2023) (0) |
| Jun 23, 2023 | 158 | Unopposed Motion to Seal and Redact - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # 1 Proposed Order)(Wilson, Samantha) Modified on 6/26/2023 (nms). (Entered: 06/23/2023) (0) |
| Jun 23, 2023 | 159 | [SEALED] Exhibits to 158 Unopposed Motion to Seal and Redact, by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 6/26/2023 (nms). (Entered: 06/23/2023) (0) |
| Jun 23, 2023 | 160 | DECLARATION of Jennifer Aggabao re 158 Unopposed Motion to Seal and Redact, by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 6/26/2023 (nms). (Entered: 06/23/2023) (4) |
| Jun 23, 2023 | 161 | DECLARATION of Jennifer Aggabao re 158 Unopposed Motion to Seal and Redact, by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 6/26/2023 (nms). (Entered: 06/23/2023) (5) |
| Jun 23, 2023 | 162 | Joint Letter to The Honorable Richard G. Andrews, from Jeremy A. Tigan, regarding narrowing of issues to be presented at the Markman hearing. (Attachments: # 1 Amended exhibits A-B to Joint Claim Construction Chart)(Tigan, Jeremy) Modified on 6/26/2023 (nms). (Entered: 06/23/2023) (0) |
| Jun 21, 2023 | 156 | ORAL ORDER: The Court intends to unseal the joint claim construction brief (D.I. 141 ) and will do so unless either party justifies the redactions that appear in the redacted version (D.I. 151 ) by the COB June 23, 2023. Ordered by Judge Richard G. Andrews on 6/21/2023. (nms) (Entered: 06/21/2023) (0) |
| Jun 20, 2023 | 154 | SO ORDERED Granting 144 Joint Motion for Claim Construction. Signed by Judge Richard G. Andrews on 6/20/2023. (nms) (Entered: 06/20/2023) (1) |
| Jun 20, 2023 | 155 | ORAL ORDER: The redacted document (D.I. 148 ) as supported by the Declaration at D.I. 149 is ACCEPTED. Ordered by Judge Richard G. Andrews on 6/20/2023. (nms) (Entered: 06/20/2023) (0) |
| Jun 16, 2023 | 151 | REDACTED VERSION of 141 Joint Claim Construction Brief by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) (Entered: 06/16/2023) (30) |
| Jun 16, 2023 | 152 | REDACTED VERSION of 142 Appendix, Volume 1, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibits A-E)(Tigan, Jeremy) Modified on 6/16/2023 (nms). (Entered: 06/16/2023) (0) |
| Jun 16, 2023 | 153 | REDACTED VERSION of 143 Appendix, Volume 2, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibits F-X)(Tigan, Jeremy) Modified on 6/16/2023 (nms). (Entered: 06/16/2023) (0) |
| Jun 15, 2023 | 150 | SO ORDERED, 146 Order in response to Oral Order (D.I. 128) and production of discovery. Signed by Judge Jennifer L. Hall on 6/15/2023. (ceg) (Entered: 06/15/2023) (3) |
| Jun 14, 2023 | 148 | REDACTED VERSION of 125 Letter, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibits 1-11)(Tigan, Jeremy) Modified on 6/14/2023 (nms). (Attachment 1 replaced on 6/29/2023) (nms). (Entered: 06/14/2023) (0) |
| Jun 14, 2023 | 149 | DECLARATION of Füsun Zeytin re 148 Redacted Document, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 6/14/2023 (nms). (Entered: 06/14/2023) (3) |
| Jun 13, 2023 | 145 | NOTICE OF SERVICE of Defendants Revance Therapeutics, Inc. and Ajinomoto Althea, Inc. d/b/a Ajinomoto Bio-Pharma Services' Responses and Objections to Plaintiffs' Second Set of Requests for Production of Documents and Things (Nos. 69-134) filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 06/13/2023) (2) |
| Jun 13, 2023 | 146 | PROPOSED Order in response to Oral Order (D.I. 128 ), by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 6/13/2023 (nms). (Entered: 06/13/2023) (3) |
| Jun 13, 2023 | 147 | REDACTED VERSION of 126 Letter by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Gaza, Anne) (Entered: 06/13/2023) (15) |
| Jun 9, 2023 | 141 | [SEALED] Joint Claim Construction Brief, filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan, Inc., Allergan USA, Inc.. (Tigan, Jeremy) Modified on 6/9/2023 (nms). (Entered: 06/09/2023) (0) |
| Jun 9, 2023 | 142 | [SEALED] Joint Apendix, Volume 1 of 2 re 141 Joint Claim Construction Brief, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibits A-E)(Tigan, Jeremy) Modified on 6/9/2023 (nms). (Entered: 06/09/2023) (0) |
| Jun 9, 2023 | 143 | [SEALED] Joint Appendix, Volume 2 of 2 re 141 Joint Claim Construction Brief, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibits F-X)(Tigan, Jeremy) Modified on 6/9/2023 (nms). (Entered: 06/09/2023) (0) |
| Jun 9, 2023 | 144 | Joint Motion for Claim Construction - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) Modified on 6/9/2023 (nms). Modified on 6/9/2023 (nms). (Entered: 06/09/2023) (1) |
| Jun 8, 2023 | 139 | STIPULATION and Proposed Order to Extend Time to file redacted versions of D.I. 125 and D.I. 126 to June 13, 2023 - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 6/8/2023 (nms). (Entered: 06/08/2023) (2) |
| Jun 8, 2023 | 140 | SO ORDERED, re 139 STIPULATION and Proposed Order to Extend Time to file redacted versions of D.I. 125 and D.I. 126 to June 13, 2023. Signed by Judge Richard G. Andrews on 6/8/2023. (nms) (Entered: 06/08/2023) (0) |
| Jun 2, 2023 | 138 | NOTICE OF SERVICE of Defendants' Surreply Claim Construction Brief filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 06/02/2023) (2) |
| Jun 1, 2023 | 137 | STIPULATION and Proposed Order to Extend Time to file redacted versions of D.I. 125 and D.I. 126 to June 8, 2023 - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 6/2/2023 (nms). (Entered: 06/01/2023) (2) |
| May 25, 2023 | 136 | STIPULATION and Proposed Order to Extend Time to file redacted versions of D.I. 125 and 126 to June 1, 2023 - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 5/26/2023 (nms). (Entered: 05/25/2023) (2) |
| May 19, 2023 | 134 | Letter to The Honorable Richard G. Andrews, from Anne Shea Gaza, regarding response to Plaintiffs' May 18, 2023 letter (D.I. 130 ). (Gaza, Anne) Modified on 5/19/2023 (nms). (Entered: 05/19/2023) (3) |
| May 19, 2023 | 135 | NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 05/19/2023) (3) |
| May 18, 2023 | 130 | Letter to The Honorable Richard G. Andrews, from Jeremy A. Tigan, regarding disputes between the parties regarding the claim construction process. (Tigan, Jeremy) Modified on 5/18/2023 (nms). (Entered: 05/18/2023) (2) |
| May 18, 2023 | 131 | Letter to The Honorable Richard G. Andrews, from Anne Shea Gaza, in response to Plaintiffs' letter dated May 18, 2023 (D.I. 130 ). (Gaza, Anne) Modified on 5/18/2023 (nms). (Entered: 05/18/2023) (1) |
| May 18, 2023 | 132 | ORAL ORDER: A conference is now set for 5/22/2023, at 10:00 AM in Courtroom 6A to discuss the disputes regarding the claim construction process (D.I. 130 ; D.I. 131 ). Attendance will be limited to local counsel only. Ordered by Judge Richard G. Andrews on 5/18/2023. (nms) (Entered: 05/18/2023) (0) |
| May 18, 2023 | 133 | STIPULATION and Proposed Order to Extend Time to file redacted versions of letters (D.I. 125 and 126) to May 25, 2023 - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 5/19/2023 (nms). (Entered: 05/18/2023) (2) |
| May 17, 2023 | 129 | STIPULATION and Proposed Order to Extend Time - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 5/17/2023 (nms). (Entered: 05/17/2023) (1) |
| May 11, 2023 | 126 | [SEALED] Letter to The Honorable Jennifer L. Hall, from Anne Shea Gaza, regarding discovery dispute. (Attachments: # 1 Exhibits A-C, # 2 Proposed Order)(Gaza, Anne) Modified on 5/11/2023 (nms). (Entered: 05/11/2023) (0) |
| May 11, 2023 | 127 | NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 69-134) filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 05/11/2023) (3) |
| May 11, 2023 | 128 | ORAL ORDER: Having reviewed the parties' letter briefs (D.I. 125, 126) regarding their Motion for Teleconference to Resolve Discovery Dispute(D.I. 121), it is hereby ORDERED that the teleconference scheduled for tomorrow, May 12, 2023, is CANCELLED and that Plaintiff's motion is DENIED without prejudice to renew. It is further ORDERED that the parties and third-party BioSentinel shall meet and confer regarding BioSentinel's proposal at D.I. 126, Ex. A, which appears to the Court that Plaintiff has not seen before today. If a dispute (regarding confidentiality, scope, or something else) remains after the meet and confer, the parties may resubmit a motion for a teleconference. If the parties come to an agreement, they may, if necessary and desired, submit a proposed order for the Court to enter. Ordered by Judge Jennifer L. Hall on 5/11/2023. (ceg) (Entered: 05/11/2023) (0) |
| May 9, 2023 | 125 | [SEALED] Letter to The Honorable Jennifer L. Hall from Jeremy A. Tigan regarding Motion to Compel. (Attachments: # 1 Exhibits 1-11)(Tigan, Jeremy) (Entered: 05/09/2023) (0) |
| May 8, 2023 | 124 | ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. 121 ). A discovery dispute teleconference is scheduled for May 12, 2023 at 3:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than COB on May 9, 2023, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than noon on May 11, 2023, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Jennifer L. Hall on 5/8/2023. (ceg) (Entered: 05/08/2023) (0) |
| May 5, 2023 | 123 | NOTICE OF SERVICE of Defendants' Answering Claim Construction Brief filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 05/05/2023) (2) |
| Apr 28, 2023 | 121 | MOTION for Teleconference to Resolve Discovery Dispute - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. Motions referred to Jennifer L. Hall.(Tigan, Jeremy) (Entered: 04/28/2023) (3) |
| Apr 28, 2023 | 122 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Second Set of Requests for Production of Documents (Nos. 132-164) filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 04/28/2023) (3) |
| Apr 7, 2023 | 120 | NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 04/07/2023) (3) |
| Apr 3, 2023 | 119 | NOTICE OF SERVICE of Plaintiffs' Objections and Supplemental Responses to Defendants' First Set of Interrogatories (Nos. 1-7) filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 04/03/2023) (3) |
| Mar 30, 2023 | 110 | Joint Claim Construction Chart, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) (Additional attachment(s) added on 3/31/2023: # 1 Exhibits 1-9) (nms). Modified on 3/31/2023 (nms). (Entered: 03/30/2023) (0) |
| Mar 30, 2023 | 112 | Joint Claim Construction Chart, Volume 2, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibit 10 part 1)(Tigan, Jeremy) Modified on 3/31/2023 (nms). (Entered: 03/30/2023) (0) |
| Mar 30, 2023 | 113 | Joint Claim Construction Chart, Volume 3, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibit 10 part 2)(Tigan, Jeremy) Modified on 3/31/2023 (nms). (Entered: 03/30/2023) (0) |
| Mar 30, 2023 | 114 | Joint Claim Construction Chart, Volume 4, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibits 11-12)(Tigan, Jeremy) Modified on 3/31/2023 (nms). (Entered: 03/30/2023) (0) |
| Mar 30, 2023 | 115 | Joint Claim Construction Chart, Volume 5, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibits 13-14)(Tigan, Jeremy) Modified on 3/31/2023 (nms). (Entered: 03/30/2023) (0) |
| Mar 30, 2023 | 116 | Joint Claim Construction Chart, Volume 6, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibit 15)(Tigan, Jeremy) Modified on 3/31/2023 (nms). (Entered: 03/30/2023) (0) |
| Mar 30, 2023 | 117 | Joint Claim Construction Chart, Volume 7, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibit 16)(Tigan, Jeremy) Modified on 3/31/2023 (nms). (Entered: 03/30/2023) (0) |
| Mar 30, 2023 | 118 | Joint Claim Construction Chart, Volume 8, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibits 17-25)(Tigan, Jeremy) Modified on 3/31/2023 (nms). (Entered: 03/30/2023) (0) |
| Mar 29, 2023 | 109 | NOTICE OF SERVICE of Defendants' Second Set of Requests for the Production of Documents and Things (Nos. 132-164) to Plaintiffs filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 03/29/2023) (2) |
| Mar 24, 2023 | 108 | STIPULATION TO EXTEND TIME for the parties to file a Joint Claim Construction Chart to March 29, 2023 - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) (Entered: 03/24/2023) (1) |
| Mar 23, 2023 | 107 | NOTICE OF SERVICE of Defendants' Supplemental Preliminary Invalidity Contentions filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 03/23/2023) (2) |
| Mar 22, 2023 | 106 | NOTICE OF SERVICE of Defendants' Identification of Claim Terms and Proposed Constructions filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 03/22/2023) (2) |
| Mar 17, 2023 | 104 | NOTICE OF SERVICE of Defendants Revance Therapeutics, Inc. and Ajinomoto Althea, Inc. d/b/a Ajinomoto Bio-Pharma Services' First Supplemental Response and Objections to Plaintiffs' Interrogatory No. 1 filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 03/17/2023) (2) |
| Mar 17, 2023 | 105 | NOTICE OF SERVICE of Plaintiffs' Identification of Claim Terms in Need of Construction filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 03/17/2023) (3) |
| Mar 3, 2023 | 103 | NOTICE OF SERVICE of Defendants' Preliminary Invalidity Contentions filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) (Entered: 03/03/2023) (2) |
| Feb 23, 2023 | 102 | MOTION for Pro Hac Vice Appearance of Attorney Sasha S. Rao - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) (Entered: 02/23/2023) (4) |
| Feb 17, 2023 | 101 | REDACTED VERSION of 100 Answer to Counterclaim by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) (Entered: 02/17/2023) (17) |
| Feb 10, 2023 | 100 | [SEALED] ANSWER to 88 Answer to Amended Complaint,, Counterclaim, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 02/10/2023) (0) |
| Feb 6, 2023 | 99 | REDACTED VERSION of 95 Exhibit to a Document by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) (Entered: 02/06/2023) (30) |
| Jan 31, 2023 | 97 | ORDER Granting Unopposed Motion to Seal Document and Redact (D.I. 94 ). Signed by Judge Richard G. Andrews on 1/31/2023. (nms) (Entered: 01/31/2023) (2) |
| Jan 31, 2023 | 98 | REDACTED VERSION of 88 Answer to Amended Complaint,, Counterclaim, by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # 1 Exhibit A - C)(Gaza, Anne) (Entered: 01/31/2023) (0) |
| Jan 30, 2023 | 94 | Unopposed Motion to Seal and Redact - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-2, # 2 Proposed Order)(Wilson, Samantha) Modified on 1/30/2023 (nms). (Entered: 01/30/2023) (0) |
| Jan 30, 2023 | 95 | [SEALED] EXHIBITS 3-4 to 94 Unopposed MOTION to Seal and Redact, by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 1/30/2023 (nms). (Entered: 01/30/2023) (0) |
| Jan 30, 2023 | 96 | DECLARATION of Jennifer Aggabao re 94 Unopposed Motion to Seal and Redact, by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 1/31/2023 (nms). (Entered: 01/30/2023) (5) |
| Jan 27, 2023 | 93 | STIPULATION and Proposed Order to Extend Time to file redacted version of Answer, Defenses, and Counterclaims (D.I. 88) to January 30, 2023 - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 1/30/2023 (nms). (Entered: 01/27/2023) (2) |
| Jan 26, 2023 | 92 | REDACTED VERSION of 85 Sealed Exhibits 3-4 to 84 Unopposed Motion to Seal and Redact, by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 1/27/2023 (nms). (Entered: 01/26/2023) (30) |
| Jan 20, 2023 | 1 | Amended Complaint* (1) |
| Jan 20, 2023 | 86 | ORDER Granting 84 Unopposed Motion to Seal and Redact. Signed by Judge Richard G. Andrews on 1/20/2023. (nms) (Entered: 01/20/2023) (1) |
| Jan 20, 2023 | 87 | NOTICE OF SERVICE of Plaintiffs' Objections and Supplemental Responses to Defendants' First Set of Interrogatories (Nos. 1-7) filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 01/20/2023) (3) |
| Jan 20, 2023 | 88 | [SEALED] ANSWER to 79 Amended Complaint, and COUNTERCLAIMS against Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc., by Revance Therapeutics, Inc., Ajinomoto Althea, Inc..(Gaza, Anne) Modified on 1/20/2023 (nms). (Additional attachment(s) added on 1/23/2023: # 1 Exhibits A-C) (nms). (Entered: 01/20/2023) (0) |
| Jan 20, 2023 | 90 | REDACTED VERSION of 76 MOTION for Leave to File Second Amended Complaint by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibits 1-44, # 3 Exhibit B)(Tigan, Jeremy) (Entered: 01/20/2023) (0) |
| Jan 20, 2023 | 91 | REDACTED VERSION of 79 Amended Complaint, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibits 1-44)(Tigan, Jeremy) (Entered: 01/20/2023) (0) |
| Jan 19, 2023 | 84 | Unopposed Motion to Seal and Redact - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 5, # 4 Proposed Order)(Wilson, Samantha) Modified on 1/20/2023 (nms). (Entered: 01/19/2023) (0) |
| Jan 19, 2023 | 85 | [SEALED] Exhibits 3-4 to 84 Unopposed Motion to Seal and Redact, by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # 1 Exhibit 4, # 2 Certificate of Service)(Wilson, Samantha) Modified on 1/20/2023 (nms). (Entered: 01/19/2023) (0) |
| Jan 14, 2023 | 1 | Amended Complaint* (1) |
| Jan 12, 2023 | 83 | ORAL ORDER: The redacted filings (D.I. 81 and D.I. 82 ) are REJECTED because parts of them are redacted in their entirety. Absent a compelling reason, supported by a statement under oath by a party, redactions in their entirety are impermissible; redactions must be done so as to redact the least possible amount of the materials submitted. Failure to make a good faith attempt at such redactions may result in sanctions, the most common of which would be simply unsealing the entire filing. Redacting in its entirety a document, or parts of it, that contains publicly available materials is prima facie evidence of bad faith. Revised redacted filings are DUE within five business days. Ordered by Judge Richard G. Andrews on 1/12/2023. (nms) (Entered: 01/12/2023) (0) |
| Jan 11, 2023 | 81 | REDACTED VERSION of 76 MOTION for Leave to File Second Amended Complaint by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibits 1-44, # 3 Exhibit B)(Tigan, Jeremy) (Main Document 81 replaced on 1/12/2023) (nms). (Entered: 01/11/2023) (0) |
| Jan 11, 2023 | 82 | REDACTED VERSION of 79 Amended Complaint, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibits 1-44)(Tigan, Jeremy) (Entered: 01/11/2023) (0) |
| Jan 4, 2023 | 80 | STIPULATION and Proposed Order to Extend Time - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 1/5/2023 (nms). (Entered: 01/04/2023) (2) |
| Dec 30, 2022 | 79 | Amended Complaint* (1) |
| Dec 30, 2022 | 78 | ORDER Granting 76 MOTION for Leave to File Second Amended Complaint. Signed by Judge Richard G. Andrews on 12/30/2022. (nms) (Entered: 12/30/2022) (1) |
| Dec 28, 2022 | 75 | STIPULATION and Proposed Order to Amend Scheduling Order Deadlines - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 12/28/2022 (nms). (Entered: 12/28/2022) (2) |
| Dec 28, 2022 | 76 | [SEALED] Motion for Leave to File Second Amended Complaint - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibits 1-44, # 3 Exhibit B)(Tigan, Jeremy) Modified on 12/28/2022 (nms). (Entered: 12/28/2022) (0) |
| Dec 28, 2022 | 77 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,332,567; 7,354,740; 8,409,828; 11,033,625; 11,124,786; 11,147,878; 11,203,748; 11,285,216; 11,326,155. (Tigan, Jeremy) Modified on 12/29/2022 (nms). (Entered: 12/28/2022) (1) |
| Dec 15, 2022 | 74 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) (Entered: 12/15/2022) (3) |
| Nov 30, 2022 | 73 | REDACTED VERSION of 71 Answer to Counterclaim by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) (Entered: 11/30/2022) (16) |
| Nov 28, 2022 | 72 | STIPULATION and Proposed Order to Extend Time - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 11/29/2022 (nms). (Entered: 11/28/2022) (1) |
| Nov 17, 2022 | 71 | [SEALED] ANSWER to 50 Counterclaims , by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) Modified on 11/18/2022 (nms). (Entered: 11/17/2022) (0) |
| Nov 14, 2022 | 70 | Order (30) Docket Text: SO ORDERED Granting [69] Stipulated Protective Order. Signed by Judge Richard G. Andrews on 11/14/2022. (nms) |
| Nov 11, 2022 | 69 | Proposed Order (30) Docket Text: PROPOSED Stipulated Protective Order, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 11/14/2022 (nms). |
| Nov 8, 2022 | 68 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Revance Therapeutics, Inc. and Ajinomoto Althea, Inc. d/b/a Ajinomoto Bio-Pharma Services' Core Technical Documents filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) |
| Oct 25, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [67] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Allergan Pharmaceuticals Ireland Unlimited Company answer due 11/17/2022; Allergan USA, Inc. answer due 11/17/2022; Allergan, Inc. answer due 11/17/2022). Signed by Judge Richard G. Andrews on 10/25/2022. (nms) |
| Oct 25, 2022 | 67 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to answer, move, or otherwise respond to Defendants' counterclaims (D.I. 50) to November 17, 2022 - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) |
| Oct 24, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Due to a scheduling conflict the discovery conference scheduled for 11/10/2022, is CANCELED. The pending discovery dispute and all future disputes are now REFERRED to Magistrate Judge Jennifer L. Hall. The parties are directed to contact Judge Hall's chambers to determine the protocol for teeing the current dispute up. Ordered by Judge Richard G. Andrews on 10/24/2022. (nms) |
| Oct 24, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: A Motion for Teleconference to Resolve Discovery Dispute should be filed if counsel finds they are unable to resolve a discovery matter. The suggested text for this motion can be found in Judge Hall's portion of the Court's website, in the "Forms" tab, under the heading "Motion for Teleconference to Resolve Discovery/Protective Order Disputes." The dispute will thereafter be addressed in accordance with Judge Hall's discovery dispute procedures. ORDERED by Judge Jennifer L. Hall on 10/24/2022. (ceg) |
| Oct 24, 2022 | 66 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants Revance Therapeutics, Inc. and Ajinomoto Althea, d/b/a Ajinomoto Bio- Pharma Services' Responses and Objections to Plaintiff's First Set of Interrogatories (Nos. 1 - 11); and 2) Revance Therapeutics, Inc. and Ajinomoto Althea, d/b/a/ Ajinomoto Bio-Pharma Services' Responses and Objections to Plaintiff's First Set of Requests for Production of Documents and Things (Nos. 1 - 68) filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) |
| Oct 20, 2022 | 62 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Rule 26 Initial Disclosures and (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) |
| Oct 20, 2022 | 63 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants' Rule 26(a)(1) Initial Disclosures, and 2) Defendants' Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) |
| Oct 19, 2022 | 61 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Production of Documents (Nos. 1-131) and (2) Plaintiffs' Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-7) filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) |
| Oct 14, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The parties have advised that a dispute has arisen regarding the protective order. The Court will hold a discovery conference on 11/10/2022, at 3:30 PM in Courtroom 6A. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Scheduling Order. Ordered by Judge Richard G. Andrews on 10/14/2022. (nms) |
| Sep 29, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [58] STIPULATION and Proposed Order to Extend Time (1) for the parties to file a proposed protective order and to answer, move, or otherwise respond to Defendants' counterclaims. Signed by Judge Richard G. Andrews on 9/29/2022. (nms) |
| Sep 29, 2022 | 58 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (1) for the parties to file a proposed protective order; and (2) for Plaintiffs to answer, move, or otherwise respond to Defendants' counterclaims (D.I. 50) to October 6, 2022 and October 25, 2022, respectively - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) |
| Sep 29, 2022 | 59 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Identification of Accused Product and Asserted Patents filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) |
| Sep 23, 2022 | 57 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories (Nos. 1-11) to Defendants Revance and Ajinomoto and (2) Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-68) to Defendants Revance and Ajinomoto filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..(Tigan, Jeremy) |
| Sep 20, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [56] STIPULATION and Proposed Order to Extend Time to answer, move, or otherwise respond to Defendants' counterclaims (*Reset Answer Deadlines: Allergan Pharmaceuticals Ireland Unlimited Company answer due 10/18/2022; Allergan USA, Inc. answer due 10/18/2022; Allergan, Inc. answer due 10/18/2022). Signed by Judge Richard G. Andrews on 9/20/2022. (nms) |
| Sep 20, 2022 | 56 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time to answer, move, or otherwise respond to Defendants' counterclaims - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 9/20/2022 (nms). |
| Sep 19, 2022 | 55 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants' First Set of Requests for the Production of Documents and Things (Nos. 1-131) to Plaintiffs; and 2) Defendants' First Set of Interrogatories to Plaintiffs (Nos. 1-7). filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..(Wilson, Samantha) |
| Sep 15, 2022 | 54 | Scheduling Order (14) Docket Text: SCHEDULING ORDER: Joinder of Parties due by 2/2/2023. Amended Pleadings due by 2/2/2023. Fact Discovery completed by 9/28/2023. Dispositive Motions due by 6/13/2024. Answering Brief due 7/11/2024. Reply Brief due 7/25/2024. Joint Claim Construction Brief due by 6/9/2023. A Markman Hearing is set for 6/28/2023, at 8:30 AM in Courtroom 6A. A Pretrial Conference is set for 11/15/2024, at 9:00 AM in Courtroom 6A. A 5 day Jury Trial is set to start 12/2/2024, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 9/15/2022. (nms) |
| Sep 14, 2022 | 53 | Proposed Order (14) Docket Text: PROPOSED Scheduling Order, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 9/14/2022 (nms). |
| Sep 6, 2022 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Rule 16(b) Scheduling Conference held on 9/6/2022. Counsel for Plaintiffs: J. Tigan. Counsel for Defendant: A. Gaza. A Jury Trial is set to begin on 12/2/2024, at 9:30 AM. A Pretrial Conference is set for 11/15/2024, at 9:00 AM. Plaintiff's counsel is directed to promptly submit a revised proposed order with the Court's rulings made at the conference. (Court Reporter Heather Triozzi.) (lah) |
| Sep 6, 2022 | 52 | Order (1) Docket Text: ORDER Granting [49] Unopposed Motion for Leave to File Under Seal. Signed by Judge Richard G. Andrews on 9/6/2022. (nms) |
| Sep 2, 2022 | 49 | Motion for Miscellaneous Relief (Main Document) (9) Docket Text: Unopposed Motion for Leave to File Under Seal - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # (1) Proposed Order)(Gaza, Anne) Modified on 9/2/2022 (nms). |
| Sep 2, 2022 | 49 | Motion for Miscellaneous Relief (Text of Proposed Order) (1) Docket Text: Unopposed Motion for Leave to File Under Seal - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # (1) Proposed Order)(Gaza, Anne) Modified on 9/2/2022 (nms). |
| Sep 2, 2022 | 51 | Redacted Document (Main Document) (30) Docket Text: REDACTED VERSION of [50] Answer to Amended Complaint,, Counterclaim, by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # (1) Exhibit A-C)(Gaza, Anne) |
| Sep 2, 2022 | 51 | Redacted Document (Exhibit A-C) (1) Docket Text: REDACTED VERSION of [50] Answer to Amended Complaint,, Counterclaim, by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # (1) Exhibit A-C)(Gaza, Anne) |
| Sep 1, 2022 | 46 | Proposed Order (16) Docket Text: PROPOSED Scheduling Order, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 9/1/2022 (nms). |
| Sep 1, 2022 | 47 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Jeremy A. Tigan regarding dial-in information for the September 6, 2022 Rule 16 conference. (Tigan, Jeremy) |
| Sep 1, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Rule 16(b) Scheduling Conference set for 9/6/2022, at 9:30 AM will now be held in Courtroom 6A. Ordered by Judge Richard G. Andrews on 9/1/2022. (nms) |
| Aug 23, 2022 | 45 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 9/6/2023, at 9:30 AM (see Order for further details). Signed by Judge Richard G. Andrews on 8/23/2022. (nms) |
| Aug 19, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: After review of the R&R (D.I. [37]), the Objections (D.I. [38]) and the Response (D.I. [43]), the Objections are OVERRULED and the R&R is ADOPTED. The motion to dismiss (D.I. [22]) is DENIED. The Court has considered the matter de novo. I agree with the Magistrate Judge that the motion was a facial, not a factual attack, on subject matter jurisdiction, notwithstanding that Revance at times called it a factual attack. I further agree with the Magistrate Judge that there was declaratory judgment jurisdiction at the time the first amended complaint was filed. I also think one paragraph objection based on judicial economy has it backwards. Ordered by Judge Richard G. Andrews on 8/19/2022. (nms) |
| Aug 18, 2022 | 43 | Response to Objections (15) Docket Text: RESPONSE to [38] Objections, by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) Modified on 8/19/2022 (nms). |
| Aug 17, 2022 | 42 | Transcript (82) Docket Text: Official Transcript of Motion to Dismiss Hearing held on 7/7/22 before Judge Jennifer L. Hall. Court Reporter Deanna Warner,Email: Warnerdeanna@gmail.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/7/2022. Redacted Transcript Deadline set for 9/19/2022. Release of Transcript Restriction set for 11/15/2022. (Triozzi, Heather) |
| Aug 8, 2022 | 40 | Letter (2) Docket Text: Letter to The Honorable Richard G. Andrews, from Samantha G. Wilson, regarding courtesy copies. (Wilson, Samantha) Modified on 8/8/2022 (nms). |
| Aug 8, 2022 | 41 | Letter (2) Docket Text: Letter to The Honorable Richard G. Andrews, from Anne Shea Gaza, regarding response to Plaintiffs' August 5, 2022 letter (D.I. [39]). (Gaza, Anne) Modified on 8/9/2022 (nms). |
| Aug 5, 2022 | 39 | Letter (2) Docket Text: Letter to The Honorable Richard G. Andrews, from Jeremy A. Tigan, regarding request for the Court to enter an order. (Tigan, Jeremy) Modified on 8/8/2022 (nms). |
| Aug 4, 2022 | 38 | Objections (17) Docket Text: OBJECTIONS to [37] Report and Recommendations, by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 8/5/2022 (nms). |
| Jul 21, 2022 | 37 | Report and Recommendations (15) Docket Text: REPORT AND RECOMMENDATION re [22] Defendants' Motion to Dismiss First Amended Complaint. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 8/4/2022. Signed by Judge Jennifer L. Hall on 7/21/2022. (ceg) |
| Jul 7, 2022 | N/A | Motion Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Motion Hearing held on 7/7/2022 via video conference re [22] Defendants' Motion to Dismiss First Amended Complaint. The Court issued its Report and Recommendation from the bench. The time to file any objections will begin once the Court has entered the written version of the Report and Recommendation. (*Court Reporter Deanna Warner.) (ceg) |
| Jun 27, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [36] MOTION for Pro Hac Vice Appearance of Attorney Anna G. Phillips, filed by Revance Therapeutics, Inc., Ajinomoto Althea, Inc.. Signed by Judge Richard G. Andrews on 6/27/2022. (nms) |
| Jun 27, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Anna G. Phillips for Ajinomoto Althea, Inc.,and Revance Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| Jun 24, 2022 | 36 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Anna G. Phillips - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) |
| Jun 22, 2022 | 35 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Mena J. Gaballah, PharmD as co-counsel. Reason for request: no longer with the firm. (Tigan, Jeremy) |
| Jun 21, 2022 | 34 | Sur-Reply Brief (Main Document) (10) Docket Text: SUR-SUR-REPLY BRIEF re [22] MOTION to Dismiss First Amended Complaint, filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # (1) Exhibit A)(Gaza, Anne) Modified on 6/21/2022 (nms). |
| Jun 21, 2022 | 34 | Sur-Reply Brief (Exhibit A) (28) Docket Text: SUR-SUR-REPLY BRIEF re [22] MOTION to Dismiss First Amended Complaint, filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # (1) Exhibit A)(Gaza, Anne) Modified on 6/21/2022 (nms). |
| Jun 7, 2022 | 33 | Sur-Reply Brief (Main Document) (8) Docket Text: SUR-REPLY BRIEF re [22] MOTION to Dismiss First Amended Complaint filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # (1) Exhibits 3-10)(Tigan, Jeremy) |
| Jun 7, 2022 | 33 | Sur-Reply Brief (Exhibits 3-10) (30) Docket Text: SUR-REPLY BRIEF re [22] MOTION to Dismiss First Amended Complaint filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Attachments: # (1) Exhibits 3-10)(Tigan, Jeremy) |
| Jun 3, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, [32] Stipulation and Order Concerning Supplemental Briefing. Allergan's sur-reply brief shall be filed within 2 business days of the Court's entry of this Order and Revance may file a five-page responsive brief within 14 days thereafter. ORDERED by Judge Jennifer L. Hall on 6/3/2022. (ceg) |
| Jun 3, 2022 | 32 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Concerning Supplemental Briefing by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) |
| Apr 7, 2022 | N/A | Order Setting Hearing on Motion (0) Docket Text: ORAL ORDER Rescheduling Hearing on Motion: The hearing on the pending Motion to Dismiss First Amended Complaint (D.I. [22]) previously scheduled for June 8, 2022 is RESCHEDULED to July 7, 2022 at 1:00 PM before Judge Jennifer L. Hall per the request of counsel. ORDERED by Judge Jennifer L. Hall on 4/7/2022. (ceg) |
| Mar 18, 2022 | N/A | Order Setting Hearing on Motion (0) Docket Text: ORAL ORDER Setting Hearing on Motion: A hearing on the pending Motion to Dismiss First Amended Complaint (D.I. [22]) is scheduled for June 8, 2022, at 10:00 AM Eastern Time via video conference before Judge Jennifer L. Hall. Each side will be allocated 25 minutes for argument. The parties shall send a joint email to Cailah_Garfinkel@ded.uscourts.gov containing the following information regarding oral argument on or before June 6, 2022: (1) a video conference link with instructions on how to join the conference; (2) a separate audio-only dial-in; and (3) a list of attendees for each party, specifying who will be presenting argument. Any video conference must be sufficient to accommodate Judge Hall, the courtroom deputy, a law clerk, and the court reporter. Any slide presentations or demonstratives that the parties wish to use during the hearing shall be emailed to Cailah_Garfinkel@ded.uscourts.gov no later than 24 hours prior to the hearing. Slide presentations or demonstratives may be presented by the parties on the video conference screen or referred to by the parties at the hearing. Once the dial-in information is received by the Court, members of the public may obtain it by contacting Chambers at Cailah_Garfinkel@ded.uscourts.gov. All participants (including any media and members of the public) are reminded that recording or broadcasting proceedings is STRICTLY PROHIBITED. All participants shall be present on the video conference no later than 10 minutes prior to the start of the hearing. ORDERED by Judge Jennifer L. Hall on 3/18/2022. (ceg) |
| Feb 14, 2022 | N/A | Order Referring Motion (0) Docket Text: ORAL ORDER: The Motion to Dismiss First Amended Complaint (D.I. [22]) is now REFERRED to Magistrate Judge Jennifer L. Hall. Ordered by Judge Richard G. Andrews on 2/14/2022. Motions referred to Jennifer L. Hall.(nms) |
| Jan 27, 2022 | 28 | Request for Oral Argument (2) Docket Text: REQUEST for Oral Argument by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc. re [22] MOTION to Dismiss First Amended Complaint. (Blumenfeld, Jack) |
| Jan 24, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Melanie R. Rupert, Carl J. Minniti, III, Chad J. Peterman, Ashley N. Mays-Williams, Krystina L. Ho, Mena J. Gaballah, Eric W. Dittmann, Bruce M. Wexler, and Amanda E. Hoffman for Allergan Pharmaceuticals Ireland Unlimited Company, for Allergan USA, Inc., and for Allergan, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (smg) |
| Jan 21, 2022 | 27 | Reply Brief (Main Document) (16) Docket Text: REPLY BRIEF re [22] MOTION to Dismiss First Amended Complaint filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # (1) Exhibit 1)(Gaza, Anne) |
| Jan 21, 2022 | 27 | Reply Brief (Exhibit 1) (3) Docket Text: REPLY BRIEF re [22] MOTION to Dismiss First Amended Complaint filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # (1) Exhibit 1)(Gaza, Anne) |
| Jan 14, 2022 | 26 | Answering Brief in Opposition (Main Document) (27) Docket Text: ANSWERING BRIEF in Opposition re [22] MOTION to Dismiss First Amended Complaint filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..Reply Brief due date per Local Rules is 1/21/2022. (Attachments: # (1) Exhibit 1-2)(Blumenfeld, Jack) |
| Jan 14, 2022 | 26 | Answering Brief in Opposition (Exhibit 1-2) (29) Docket Text: ANSWERING BRIEF in Opposition re [22] MOTION to Dismiss First Amended Complaint filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc..Reply Brief due date per Local Rules is 1/21/2022. (Attachments: # (1) Exhibit 1-2)(Blumenfeld, Jack) |
| Jan 12, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [24] MOTION for Pro Hac Vice Appearance of Attorney Eric W. Dittmann, Chad J. Peterman, Melanie R. Rupert, Bruce M. Wexler, Ashley N. Mays-Williams, Krystina L. Ho, Carl J. Minniti, III, and Mena J. Gaballah, filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan, Inc., Allergan USA, Inc.. Signed by Judge Richard G. Andrews on 1/12/2022. (nms) |
| Jan 12, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [25] MOTION for Pro Hac Vice Appearance of Attorney Amanda E. Hoffman, filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan, Inc., Allergan USA, Inc.. Signed by Judge Richard G. Andrews on 1/12/2022. (nms) |
| Jan 12, 2022 | 24 | Motion for Leave to Appear Pro Hac Vice (11) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Eric W. Dittmann, Chad J. Peterman, Melanie R. Rupert, Bruce M. Wexler, Ashley N. Mays-Williams, Krystina L. Ho, Carl J. Minniti, III, and Mena J. Gaballah - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) |
| Jan 12, 2022 | 25 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Amanda E. Hoffman - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) |
| Dec 17, 2021 | 22 | Motion to Dismiss/Lack of Subject Jurisdiction (Main Document) (3) Docket Text: MOTION to Dismiss First Amended Complaint - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # (1) Text Proposed Order)(Gaza, Anne) Modified on 12/20/2021 (nms). |
| Dec 17, 2021 | 22 | Motion to Dismiss/Lack of Subject Jurisdiction (Text of Proposed Order) (1) Docket Text: MOTION to Dismiss First Amended Complaint - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # (1) Text Proposed Order)(Gaza, Anne) Modified on 12/20/2021 (nms). |
| Dec 17, 2021 | 23 | Opening Brief in Support (27) Docket Text: OPENING BRIEF in Support re [22] MOTION to Dismiss First Amended Complaint, filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..Answering Brief/Response due date per Local Rules is 1/3/2022. (Gaza, Anne) Modified on 12/20/2021 (nms). |
| Dec 15, 2021 | 20 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Regarding Name Change and to Amend Case Caption by Allergan Pharmaceuticals Ireland, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy) |
| Dec 15, 2021 | 21 | SO ORDERED (2) Docket Text: SO ORDERED, Granting [20] Stipulation and Proposed Order Regarding Name Change and to Amend Case Caption. Signed by Judge Richard G. Andrews on 12/15/2021. (nms) |
| Dec 3, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [19] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Ajinomoto Althea, Inc. answer due 12/17/2021; Revance Therapeutics, Inc. answer due 12/17/2021). Signed by Judge Richard G. Andrews on 12/3/2021. (nms) |
| Dec 3, 2021 | 19 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time for Defendants to move against, answer, or otherwise respond to the First Amended Complaint to and including December 17, 2021; and the time for Plaintiffs to answer, move against, or otherwise respond to the foregoing filing is extended to and including to January 14, 2022 - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) Modified on 12/3/2021 (nms). |
| Nov 29, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ryan E. Conkin, Adam C. LaRock, and Dennies Varughese for Ajinomoto Althea, Inc., and Revance Therapeutics, Inc added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (smg) Modified on 11/29/2021 (smg). |
| Nov 24, 2021 | 16 | Amended Complaint* (1) |
| Nov 24, 2021 | 16 | Amended Complaint (Main Document) (30) Docket Text: First Amended Complaint for Patent Infringement against Ajinomoto Althea, Inc., Revance Therapeutics, Inc. - filed by Allergan, Inc., Allergan Pharmaceuticals Ireland, Allergan USA, Inc.. (Attachments: # (1) Exhibits 1-36)(Blumenfeld, Jack) Modified on 11/29/2021 (nms). |
| Nov 24, 2021 | 16 | Amended Complaint (Exhibits 1-36) (30) Docket Text: First Amended Complaint for Patent Infringement against Ajinomoto Althea, Inc., Revance Therapeutics, Inc. - filed by Allergan, Inc., Allergan Pharmaceuticals Ireland, Allergan USA, Inc.. (Attachments: # (1) Exhibits 1-36)(Blumenfeld, Jack) Modified on 11/29/2021 (nms). |
| Nov 24, 2021 | 17 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,332,567 ;7,354,740 ;8,409,828 ;11,033,625 ;11,124,786 ;11,147,878 . (Blumenfeld, Jack) |
| Nov 24, 2021 | 18 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Allergan USA, Inc. filed by Allergan Pharmaceuticals Ireland, Allergan USA, Inc., Allergan, Inc.. (Blumenfeld, Jack) |
| Nov 15, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] STIPULATION and Proposed Order to Extend Time(*Reset Briefing Schedule: re [10] MOTION to Dismiss. Answering Brief due 12/1/2021). Signed by Judge Richard G. Andrews on 11/15/2021. (nms) |
| Nov 15, 2021 | 15 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Allergan Pharmaceuticals Ireland, Allergan, Inc.. (Blumenfeld, Jack) Modified on 11/15/2021 (nms). |
| Nov 5, 2021 | 13 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ajinomoto Co., Inc. for Ajinomoto Althea, Inc. filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) |
| Nov 5, 2021 | 14 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Revance Therapeutics, Inc.. (Wilson, Samantha) |
| Nov 4, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm. D., Eldora L. Ellison, Ph.D., Adam C. LaRock, Olga A. Partington, Ph.D., and Ryan E. Conkin, filed by Revance Therapeutics, Inc., Ajinomoto Althea, Inc.. Signed by Judge Richard G. Andrews on 11/4/2021. (nms) |
| Nov 3, 2021 | 10 | Motion to Dismiss/Lack of Subject Jurisdiction (Main Document) (2) Docket Text: MOTION to Dismiss - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # (1) Proposed Order)(Gaza, Anne) Modified on 11/4/2021 (nms). |
| Nov 3, 2021 | 10 | Motion to Dismiss/Lack of Subject Jurisdiction (Text of Proposed Order) (2) Docket Text: MOTION to Dismiss - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Attachments: # (1) Proposed Order)(Gaza, Anne) Modified on 11/4/2021 (nms). |
| Nov 3, 2021 | 11 | Opening Brief in Support (26) Docket Text: OPENING BRIEF in Support re [10] MOTION to Dismiss, filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc..Answering Brief/Response due date per Local Rules is 11/17/2021. (Gaza, Anne) Modified on 11/4/2021 (nms). |
| Nov 3, 2021 | 12 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm. D., Eldora L. Ellison, Ph.D., Adam C. LaRock, Olga A. Partington, Ph.D., and Ryan E. Conkin - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Wilson, Samantha) |
| Oct 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION and Proposed Order to Extend Time to move against, answer, or otherwise respond to the Complaint (*Reset Answer Deadlines: Ajinomoto Althea, Inc. answer due 11/24/2021; Revance Therapeutics, Inc. answer due 11/24/2021). Signed by Judge Richard G. Andrews on 10/19/2021. (nms) |
| Oct 18, 2021 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants to move against, answer, or otherwise respond to the Complaint for Patent Infringement to November 24, 2021 - filed by Ajinomoto Althea, Inc., Revance Therapeutics, Inc.. (Gaza, Anne) |
| Oct 6, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Oct 4, 2021 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Allergan, Inc., Allergan Pharmaceuticals Ireland. Revance Therapeutics, Inc. served on 10/4/2021, answer due 10/25/2021. (Dellinger, Megan) |
| Oct 4, 2021 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Allergan, Inc., Allergan Pharmaceuticals Ireland. Ajinomoto Althea, Inc. served on 10/4/2021, answer due 10/25/2021. (Dellinger, Megan) |
| Oct 1, 2021 | 1 | Complaint* (1) |
| Oct 1, 2021 | 1 | Complaint (Main Document) (25) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Ajinomoto Althea, Inc., Revance Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3712877.) - filed by Allergan, Inc., Allergan Pharmaceuticals Ireland. (Attachments: # (1) Exhibit 1-26, # (2) Civil Cover Sheet)(twk) |
| Oct 1, 2021 | 1 | Complaint (Exhibit 1-26) (30) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Ajinomoto Althea, Inc., Revance Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3712877.) - filed by Allergan, Inc., Allergan Pharmaceuticals Ireland. (Attachments: # (1) Exhibit 1-26, # (2) Civil Cover Sheet)(twk) |
| Oct 1, 2021 | 1 | Complaint (Civil Cover Sheet) (1) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Ajinomoto Althea, Inc., Revance Therapeutics, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3712877.) - filed by Allergan, Inc., Allergan Pharmaceuticals Ireland. (Attachments: # (1) Exhibit 1-26, # (2) Civil Cover Sheet)(twk) |
| Oct 1, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Oct 1, 2021 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,332,567 B2; 7,354,740 B2; 8,409,828 B2; 11,033,625 B2; 11,124,786 B2. (twk) |
| Oct 1, 2021 | 4 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Allergan Pharmaceuticals Ireland, Allergan, Inc. filed by Allergan Pharmaceuticals Ireland, Allergan, Inc.. (twk) |
| Oct 1, 2021 | 5 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Ajinomoto Althea, Inc. on 10/4/2021. (twk) |
| Oct 1, 2021 | 6 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Revance Therapeutics, Inc. on 10/4/2021. (twk) |
